Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.

Kaiser Permanente Ventures and Samsung Next invested in the digital mental health treatment developer through a series B round that will fund product development and commercialisation.

Engrail Therapeutics has completed a series A round led by Nan Fung Life Sciences as it targets a validated mechanism-based approach to nervous system treatments.

Optum Ventures co-led a series B round that took the chronic disease management platform's total funding to $50m.

Seed investor Toyota AI Ventures returned to help the intelligent forklift developer close a series A round led by Innovation Endeavors.

The agricultural product and services provider added $100m to a FedEx-backed round that reportedly values it at $3.5bn.

Material Impact has participated in a series C1 round for Zero Mass Water, the ASU spinout that has created a system to convert air and sunlight to drinking water.

MassMutual Ventures, Synchrony and Blue Venture Fund all returned as the user authentication platform developer almost doubled its overall funding.

Access Industries helped supply $33m in equity funding for the cloud management software developer, which also unlocked up to $20m in venture debt financing.

Kaiser Permanente contributed to a round that pushed the total raised by the Stanford-aligned cellular cancer therapy developer to $300m.